Company intelligence / Profile preview

Apollo Technology Capital

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Apollo Technology Capital is one of the largest shareholders of MediPharm Labs (owning roughly 3% of common stock). It has filed proxy materials and run public campaigns to install new board members and enact major operational and governance changes at MediPharm Labs, a medical cannabis company. Apollo's initiatives focus on improving financial results and addressing perceived management failings, particularly following steep declines in MediPharm's stock price[4][5][6].

Industry: Investors

Beyond the preview

Go deeper on Apollo Technology Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apollo Technology Capital.

Explore the full profile